Patent details

Basic Information

Publication number:

EP3417857

PCT Application Number:

CN2017073868

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP177526852

PCT Publication Number:

WO2017140253

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PHARMACEUTICAL COMPOSITION CONTAINING IMIDAZOLINE DERIVATIVE

French Title of Invention:

COMPOSITION PHARMACEUTIQUE CONTENANT UN DÉRIVÉ D'IMIDAZOLINE

German Title of Invention:

PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT EINEM IMIDAZOLINDERIVAT

SPC Number:

Dates

Filing date:

17/02/2017

Grant date:

19/07/2023

EP Publication Date:

26/12/2018

PCT Publication Date:

24/08/2017

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

19/07/2023

EP B1 Publication Date:

19/07/2023

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

17/02/2024

Expiration date:

17/02/2037

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

12/07/2023

 

 

Name:

Jiangsu Hengrui Pharmaceuticals Co., Ltd.

Address:

No. 7 Kunlunshan Road, Economic and Technological Development Zone Lianyungang Jiangsu 222047, China (CN)

Inventor

1

Name:

ZHANG, Daimei

Address:

China (CN)

2

Name:

ZHANG, Xinhua

Address:

China (CN)

3

Name:

LU, Yun

Address:

China (CN)

Priority

Priority Number:

201610093969

Priority Date:

19/02/2016

Priority Country:

China (CN)

Classification

IPC classification:

A61K 31/4166; A61K 9/20; A61K 9/16; A61P 35/00;

Publication

European Patent Bulletin

Issue number:

202329

Publication date:

19/07/2023

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages